Nucleotide-binding, oligomerization domain (NOD)-like receptor family, pyrin domain containing 3 (NLRP3) gene polymorphisms have been reported to be associated with susceptibility, disease activity and anti-tumour necrosis factor (TNF) treatment response in RA. This evidence concerns the gene NLRP3 and rheumatoid arthritis.